Review of Treatment Regimens for Mucormycosis in a Las Vegas County Hospital Between 2013 and 2017

作者
Angela Holly Villamagna,Ian Adrian F. Frani,Kimberly D. Leuthner,Shadaba Asad
出处
期刊:Open Forum Infectious Diseases [Oxford University Press]
卷期号:4 (suppl_1): S87-S87
标识
DOI:10.1093/ofid/ofx163.042
摘要

Abstract Background Mucormycosis (MC) is a group of invasive fungal infections with a mortality rate approaching 100% in disseminated disease. The incidence of MC is low, with one study estimating 500 cases/year in the United States, making optimal treatment difficult to identify. Liposomal amphotericin B (L-ampho), along with aggressive surgical intervention, is the first-line treatment for MC. Isavuconazole (ISA) and posaconazole (POSA) are newer azoles used as salvage therapy in patients not improving with L-ampho. Limited data are available about the use of L-ampho in combination with ISA or POSA as an initial treatment regimen, but aggressive treatment empirically may increase favorable outcomes. Methods We performed a retrospective review of patients diagnosed with MC from 2013 to2017 at University Medical Center of Southern Nevada in Las Vegas, Nevada. Data collected included patient demographics, comorbidities, and predisposing risk factors as well as treatment regimens. Patients were evaluated for outcome after treatment therapy with monotherapy (L-ampho, POSA or ISA) or combination therapy (L-ampho with ISA). Results From 2013 to 2017, seven cases of MC were identified – five rhinocerebral (RC), one cutaneous (CT), and 1onepulmonary (PM). The most common risk factor was uncontrolled diabetes (5/7), followed by HIV (2/7) and non-Hodgkin lymphoma (1/7). Fifty-seven percent of patients received monotherapy and 43% received combination therapy (L-ampho/ISA). All the patients receiving combination therapy had RC. Seventy-one percent of patients survived to discharge regardless of treatment regimen. One hundred percent of combination therapy patients survived to discharge, whereas 50% of monotherapy patients survived to discharge. The two mortalities were patients with PM and CT MC. Conclusion MC is a rare infection with high mortality. For this reason, we are using ISA in combination with L-ampho as initial treatment to improve clinical outcomes. With our limited experience, combination therapy showed better rates of survival to discharge, without increasing adverse events. Our data suggest the use of combination therapy may improve outcomes in MC, but a larger sample of patients treated with initial combination therapy is required to strengthen conclusions about patient outcomes. Disclosures All authors: No reported disclosures.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
YUAN发布了新的文献求助10
1秒前
anan完成签到,获得积分10
2秒前
2秒前
2秒前
Jennie发布了新的文献求助30
2秒前
coisini发布了新的文献求助10
3秒前
求知完成签到,获得积分10
3秒前
wanci的应助被孤独超短裙采纳,获得10
3秒前
3秒前
3秒前
3秒前
111发布了新的文献求助10
4秒前
4秒前
WANG发布了新的文献求助10
4秒前
5秒前
湾蓝发布了新的文献求助10
5秒前
5秒前
5秒前
冷傲碧玉完成签到,获得积分10
6秒前
6秒前
will发布了新的文献求助10
6秒前
打打的应助被0001采纳,获得30
6秒前
7秒前
7秒前
小麻发布了新的文献求助10
7秒前
Jasper的应助被624794951采纳,获得10
7秒前
8秒前
方远锋完成签到,获得积分10
8秒前
香草冰激凌完成签到,获得积分10
8秒前
8秒前
8秒前
amorcsn发布了新的文献求助20
9秒前
简单的千凝完成签到,获得积分10
9秒前
9秒前
丘比特的应助被ZZ采纳,获得10
9秒前
yy发布了新的文献求助10
9秒前
完美世界的应助被威alisa采纳,获得10
9秒前
超帅的莺发布了新的文献求助10
9秒前
菜园子完成签到,获得积分10
9秒前
李健的小迷弟的应助被绵绵冰采纳,获得10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8162621
求助须知:如何正确求助?哪些是违规求助? 9556889
关于积分的说明 21737583
捐赠科研通 7753002
什么是DOI,文献DOI怎么找? 3427836
关于科研通互助平台的介绍 2552719
邀请新用户注册赠送积分活动 2472507